Topic
Topic
Palvella Therapeutics presented clinical and claims data at a dermatology conference, pairing trial results with real-world analysis in a move aimed at adoption and reimbursement conversations.
Dupilumab produced positive outcomes in patients with skin of color, according to a real-world study covered in Managed Healthcar…
Cureus publishes a patient-reported outcomes study of Aptos thread-centered treatment in real-world aesthetic practice, expanding…
A new Cureus paper puts patient-reported outcomes at the center of Aptos thread-lift evaluation, reporting results from routine a…
Organon will present a new real-world analysis of VTAMA® (tapinarof) cream, 1%, at the 2026 Fall Clinical Dermatology Conference,…
LEO Pharma presented new tralokinumab data at EADV 2026 on real-world outcomes and quality of life in adults and adolescents with…
Avelumab demonstrates effectiveness against Merkel cell carcinoma in a real-world population, Medscape reports, extending evidenc…
LEO Pharma used EADV 2026 to present real-world tralokinumab data on outcomes and quality of life in adults and adolescents with…
Real-world evidence supports long-term dupilumab use in children with atopic dermatitis, AJMC reports, strengthening payer and cl…
A Cureus study reports patient-reported outcomes after Aptos thread-centered facial treatment in real-world aesthetic practice, a…